Immunopeptidomics can inform the design of mRNA vaccines for the delivery of <i>Mycobacterium tuberculosis</i> MHC class II antigens

Owen Leddy(University of Chicago), Bryan D. Bryson(Massachusetts Institute of Technology), Mary Carrington(Ragon Institute of MGH, MIT and Harvard), Paul Ogongo(University of California, San Francisco), Julia Huffaker(University of California, San Francisco), Yuko Yuki(Frederick National Laboratory for Cancer Research), Liya Wassie(Armauer Hansen Research Institute), R. A. Milligan(Ragon Institute of MGH, MIT and Harvard), Mingyu Gan(University of North Carolina at Chapel Hill), Kidist Bobosha(Armauer Hansen Research Institute), Qingyun Liu(Ministry of Education of the People's Republic of China), J. Ernst(University of California, San Francisco), Forest M. White(Center for Cancer Research), Sheikh Mahmud(Massachusetts Institute of Technology), Heyuan Michael Ni(Massachusetts Institute of Technology)
Science Translational Medicine
November 5, 2025
Cited by 9


Related Papers